Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginInterest Coverage RatioInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on SalesTimes Interest Earned

vTv Therapeutics (VTVT) Return on Sales (2016 - 2025)

vTv Therapeutics' Return on Sales history spans 12 years, with the latest figure at 1669.35% for Q3 2025.

  • For Q3 2025, Return on Sales fell 164664.0% year-over-year to 1669.35%; the TTM value through Sep 2025 reached 1669.35%, down 164664.0%, while the annual FY2024 figure was 22.33%, N/A changed from the prior year.
  • Return on Sales for Q3 2025 was 1669.35% at vTv Therapeutics, down from 1404.35% in the prior quarter.
  • Across five years, Return on Sales topped out at 0.49% in Q3 2021 and bottomed at 3068.33% in Q3 2023.
  • The 5-year median for Return on Sales is 357.78% (2022), against an average of 779.09%.
  • The largest annual shift saw Return on Sales plummeted -305423bps in 2023 before it skyrocketed 304562bps in 2024.
  • A 5-year view of Return on Sales shows it stood at 1052.0% in 2021, then surged by 36bps to 676.67% in 2022, then plummeted by -353bps to 3068.33% in 2023, then soared by 91bps to 261.0% in 2024, then crashed by -540bps to 1669.35% in 2025.
  • Per Business Quant, the three most recent readings for VTVT's Return on Sales are 1669.35% (Q3 2025), 1404.35% (Q2 2025), and 1347.24% (Q1 2025).